Cycle Capital

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and create value out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Founded in 1928, Wellington Management Company is an investment managing firm headquartered in Boston, Massachusetts. The firm provides provides services to to high net worth individuals, banking and thrift institutions, pension and profit sharing plans, endowment and foundations, insurers, intermediaries and wealth managers, state and municipal government entities, charitable organizations, family offices and consultants. The firm invests in growth and value stocks of small-cap, mid-cap and large-cap companies. It launches and manages equity, fixed income, balanced mutual funds and hedge funds for its clients.

Founded by celebrated technologist and entrepreneur, Mike Lynch OBE FREng FRS, Invoke Capital founds, invests in and advises fast-growing fundamental technology companies in Europe. With deep expertise in identifying and commercialising artificial intelligence research and a close relationship with the University of Cambridge, Invoke exists to realise the commercial possibilities of Britain’s extraordinary science and deep technology base.

Beringea is a private equity firm which seeks to invest across a range of sectors such as media, healthcare, life science, internet technologies, advanced manufacturing, clean-tech and specialized consumer goods. The firm was founded in 1988 and is headquartered in Farmington Hills, Michigan with an additional office in London, United Kingdom.

Jenny joined Lansdowne Partners in April 2014. Prior to this, Jenny was the Investor Relations representative at Habrok Capital Management, a global long/short equity hedge fund based in London. Jenny began her career at Habrok in 2006 (then part of Trafelet Delta Funds), where she managed all client relationships globally.

We back the world’s most ambitious sci-entrepreneurs to turn bold science into healthcare ventures at the frontier of Bio-AI. We help you go from lab bench to first-in-human faster — engineering companies that are scientifically rigorous, commercially viable, investment-ready, and clinically meaningful.